Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -17.44% | -23.47% | -17.98% | -0.82% | 29.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.44% | -23.47% | -17.98% | -0.82% | 29.88% |
| Cost of Revenue | -37.75% | -32.55% | -15.89% | 8.41% | 61.26% |
| Gross Profit | 23.06% | -7.47% | -21.35% | -15.11% | -6.41% |
| SG&A Expenses | -4.38% | 7.56% | 26.62% | 43.39% | 110.75% |
| Depreciation & Amortization | -30.50% | -13.75% | 11.92% | 47.99% | 173.85% |
| Other Operating Expenses | -64.14% | -123.18% | -155.72% | 100.00% | -25.92% |
| Total Operating Expenses | -21.97% | -15.37% | 2.13% | 26.65% | 77.70% |
| Operating Income | 29.56% | -4.08% | -70.58% | -134.23% | -362.51% |
| Income Before Tax | -42.83% | -79.00% | -135.76% | -185.77% | -139.23% |
| Income Tax Expenses | 41.77% | 421.21% | -- | -- | 109.19% |
| Earnings from Continuing Operations | -42.83% | -79.06% | -135.89% | -185.89% | -141.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,005.88% | 507.41% | -- | -- | -- |
| Net Income | -42.75% | -78.88% | -135.69% | -185.56% | -141.59% |
| EBIT | 29.56% | -4.08% | -70.58% | -134.23% | -362.51% |
| EBITDA | 29.96% | -7.31% | -85.58% | -159.12% | -360.86% |
| EPS Basic | -40.38% | -77.71% | -136.97% | -172.35% | -56.54% |
| Normalized Basic EPS | 14.08% | -9.30% | -47.70% | -70.56% | -56.74% |
| EPS Diluted | -39.70% | -77.87% | -134.58% | -182.68% | -60.80% |
| Normalized Diluted EPS | 14.08% | -9.30% | -47.53% | -70.34% | -56.57% |
| Average Basic Shares Outstanding | 3.67% | 3.26% | 10.25% | 21.67% | 38.48% |
| Average Diluted Shares Outstanding | 3.67% | 3.26% | 4.57% | 14.72% | 29.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |